State of Wisconsin Investment Board’s Translate Bio, Inc. Common Stock TBIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-107,700
Closed -$2.97M 2195
2021
Q2
$2.97M Sell
107,700
-2,500
-2% -$49.1K 0.01% 1192
2021
Q1
$1.82M Buy
110,200
+1,100
+1% +$25.1K ﹤0.01% 1254
2020
Q4
$2.01M Buy
109,100
+3,500
+3% +$62.6K ﹤0.01% 1203
2020
Q3
$1.44M Buy
105,600
+49,000
+87% +$755K ﹤0.01% 1220
2020
Q2
$1.01M Buy
56,600
+3,200
+6% +$48.3K ﹤0.01% 1238
2020
Q1
$532K Buy
53,400
+10,500
+24% +$86K ﹤0.01% 1335
2019
Q4
$349K Hold
42,900
﹤0.01% 1520
2019
Q3
$425K Hold
42,900
﹤0.01% 1378
2019
Q2
$542K Buy
42,900
+29,900
+230% +$315K ﹤0.01% 1303
2019
Q1
$132K Buy
13,000
+2,900
+29% +$22.2K ﹤0.01% 1491
2018
Q4
$76K Buy
+10,100
New +$74K ﹤0.01% 1510

State of Wisconsin Investment Board's TBIO Position: Q3 2021 in Review

State of Wisconsin Investment Board sold out of Translate Bio, Inc. Common Stock (TBIO) in Q3 2021, closing a stake of 107,700 shares — an estimated $2.97M sold.

State of Wisconsin Investment Board first reported a position in TBIO in Q4 2018 and held it in 11 quarters. The position peaked at $2.97M in Q2 2021. 0 funds tracked by Wall St. Rank hold TBIO as of Q3 2021.

  • State of Wisconsin Investment Board reported no remaining Translate Bio, Inc. Common Stock position as of Q3 2021 after selling out during the quarter.
  • State of Wisconsin Investment Board sold 107,700 Translate Bio, Inc. Common Stock shares in Q3 2021, an estimated $2.97M.
  • State of Wisconsin Investment Board first reported a position in Translate Bio, Inc. Common Stock in Q4 2018 and held it in 11 quarters.
  • State of Wisconsin Investment Board's Translate Bio, Inc. Common Stock position peaked at $2.97M in Q2 2021.
  • 0 funds tracked by Wall St. Rank held Translate Bio, Inc. Common Stock as of Q3 2021.

Based on State of Wisconsin Investment Board's 13F filing for Q3 2021, filed 12 Nov 2021.